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Background: Chronic pain may involve connective tissue remodeling due to inflammatory mediators.
Results: Histamine H1 receptor activation causes ATP release from human subcutaneous fibroblasts via pannexin-1
hemichannels.
Conclusion: Responses of skin fibroblasts to histamine are amplified by autocrine ATP release and P2Y1 purinoceptor
activation.
Significance: Amplification of histamine-mediated Ca2 mobilization and growth of human fibroblasts by purines may be a
novel therapeutic target for painful fibrotic diseases.
Changes in the regulation of connective tissue ATP-mediated
mechano-transduction and remodeling may be an important
link to the pathogenesis of chronic pain. It has been demon-
strated thatmast cell-derived histamine plays an important role
in painful fibrotic diseases.Herewe analyzed the involvement of
ATP in the response of human subcutaneous fibroblasts to his-
tamine. Acute histamine application caused a rise in intracellu-
lar Ca2 ([Ca2]i) and ATP release from human subcutaneous
fibroblasts via H1 receptor activation. Histamine-induced
[Ca2]i rise was partially attenuated by apyrase, an enzyme that
inactivates extracellularATP, and by blockingP2 purinoceptors
with pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid)
tetrasodium salt and reactive blue 2. [Ca2]i accumulation
caused by histamine was also reduced upon blocking pan-
nexin-1 hemichannels with 10Panx, probenecid, or carben-
oxolone but not when connexin hemichannels were inhibited
with mefloquine or 2-octanol. Brefeldin A, an inhibitor of
vesicular exocytosis, also did not block histamine-induced
[Ca2]i mobilization. Prolonged exposure of human subcuta-
neous fibroblast cultures to histamine favored cell growth
and type I collagen synthesis via the activation of H1 receptor.
This effect was mimicked by ATP and its metabolite, ADP,
whereas the selective P2Y1 receptor antagonist, MRS2179, par-
tially attenuated histamine-induced cell growth and type I col-
lagen production. Expression of pannexin-1 and ADP-sensitive
P2Y1 receptor on human subcutaneous fibroblasts was con-
firmed by immunofluorescence confocal microscopy and
Western blot analysis. In conclusion, histamine induces ATP
release from human subcutaneous fibroblasts, via pannexin-1
hemichannels, leading to [Ca2]i mobilization and cell
growth through the cooperation of H1 and P2 (probably P2Y1)
receptors.
Unspecialized connective tissue forms an anatomical mesh
throughout the body, which acts as a body-wide mechanosen-
sitive signaling network (1, 2). Despite its overwhelming size,
the relative importance of unspecialized connective tissue has
been generally overlooked ormisunderstood; it was considered
as relatively superfluous apart from its supporting role among
more specialized tissues (2). Nowadays, evidence suggests that
increased connective tissue disorganization may be an impor-
tant link in the pathogenesis of chronic musculoskeletal pain,
such as low back pain (3, 4), and we hypothesized that this
might also occur in fibromyalgia.
Like the skin, the underlying subcutaneous connective tissue
is richly innervated by sensory nerve endings, includingmecha-
noceptors, nociceptors, and thermoceptors (5, 6). Therefore,
sensory inputs arising from affected connective tissuemay alter
the activity of nociceptors. Conversely, activation of nocicep-
tors causes the release of substance P from sensory C-fibers,
which triggers the production of inflammatory mediators, like
histamine and several cytokines, from neighboring cells (7). It
was demonstrated that substance P and histamine augment
cytokine-induced proliferation of dermal fibroblasts, thus indi-
cating that mast cell-derived histamine may be a key player in
the induction of tissue fibrosis in painful fibrotic diseases (8). In
view of this, nociceptor activation may by itself contribute to
prolong inflammation and to exaggerate tissue fibrosis.
Inflammatory mediators, such as cytokines and histamine,
are essential to the onset and maintenance of inflammatory
reactions (9). In addition, adenine and uracil nucleotides have
also been related to the pathophysiology of chronic inflamma-
tion (10). Besides their acute actions, nucleotides exert auto-
crine and/or paracrine activities regulating cellular processes
like proliferation and differentiation of human cells (11). Inter-
estingly, it has been described that smooth muscle and epithe-
lial cells release ATP in response to histamine (12), but this was
never demonstrated in fibroblasts. Therefore, we postulated
that inflammatory mediators, like histamine, could influence
connective tissue plasticity through the release of ATP from
fibroblasts, the predominant cell type of this tissue, leading to
signal amplification via P2 purinoceptors located in neighbor-
ing cells.
Nucleotides reach the external milieu via both lytic and non-
lytic mechanisms from various cell types upon mechanical or
chemical stimulation. Nucleotide-releasing pathways include
1) electrodiffusional movement through membrane ion chan-
nels, including pannexin and connexin hemichannels; 2) facili-
tated diffusion by nucleotide-specific ATP-binding cassette
transporters; and 3) cargo vesicle trafficking and exocytotic
granule secretion (13). The extent of the paracrine activity
mediated by ATP and/or related released nucleotides may be
limited by the presence of membrane-bound nucleotide-me-
tabolizing enzymes. Ectonucleotidases sequentially catabolize
nucleoside 5-triphosphates to their respective nucleoside
5-di- and monophosphates, nucleosides, and free phosphates
or pyrophosphate, which can all appear in the extracellular fluid
at the same time (13). Although a comprehensive study on the
kinetics of extracellular catabolism of adenine nucleotides and
adenosine formation in the human musculoskeletal system is
still lacking, the coexistence of various metabolic pathways for
the nucleotide extracellular hydrolysis represents an opportu-
nity for regulating cell-specific responses to surrounding ade-
nine nucleotides and for terminating purinergic actions.
Therefore, this study was designed to investigate if the
response of human subcutaneous fibroblasts to histamine
involves a purinergic loop consisting in the release of ATP, for-
mation of its biological active metabolites (namely ADP), and
subsequent activation of P2 purinoceptors. Understanding the
mechanisms underlying the purinergic amplification loop reg-
ulating cell signaling and subcutaneous tissue remodeling trig-
gered by inflammatory mediators may highlight new therapeu-
tic strategies for chronic painful conditions.
EXPERIMENTAL PROCEDURES
Materials and Reagents—Materials and reagents are described
in detail in the supplemental Experimental Procedures.
Cell Cultures—Human fibroblasts were isolated from the
subcutaneous tissue of organ donors (52  5 years old
(means S.E. of the mean), n 16) with no clinical history of
connective tissue disorders. The protocol was approved by the
Ethics Committee of Hospital Geral de SantoAnto´nio SA (Uni-
versity Hospital) and of the Instituto de Cieˆncias Biome´dicas de
Abel Salazar (Medical School) of the University of Porto. The
investigation conforms to the principles outlined in the Declara-
tion of Helsinki. Subcutaneous tissues weremaintained at 4–6 °C
inM-400 transplantation solution (4.190g/100mlmannitol, 0.205
g/100mlKH2PO4, 0.970 g/100mlK2HPO43H2O, 0.112 g/100ml
KCl, and 0.084 g/100ml NaHCO3, pH 7.4) until used, which was
between 2 and 16 h after being harvested (14). Cells were then
obtained by the explant technique and cultured in DMEM sup-
plemented with 10% fetal bovine serum (FBS), 2.5 g/ml
amphotericin B, and 100 units/ml penicillin/streptomycin at
37 °C in a humidified atmosphere of 95% air and 5% CO2.
Medium was replaced twice a week. Primary cultures were
maintained until near confluence (3–4 weeks), and then
adherent cells were enzymatically released with 0.04% trypsin-
EDTA solution plus 0.025% type I collagenase in phosphate-
buffered saline (PBS). The resultant cell suspension was cul-
tured andmaintained in the same conditionsmentioned above.
All of the experiments were performed in the first subculture.
Extracellular ATP Quantification by Bioluminescence—Ex-
tracellular ATP was quantified by the luciferin-luciferase ATP
bioluminescence assay kit HS II (RocheApplied Science), using
a multidetection microplate reader (Synergy HT, BioTek
Instruments). Briefly, cells were seeded in flat bottom 96-well
plates at a density of 3 104 cells/ml for 21 days. At the begin-
ning of the experiment, cells were washed twice with Tyrode’s
solution (137 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, 0.4 mMNaH2PO4, 11.9 mMNaHCO3, and 11.2 mM glu-
cose, pH7.4) at 37 °C and allowed to rest for 30min (basal), after
which samples were collected (75 l). Subsequently, histamine
(100 M) was added. Samples were collected at five different
incubation times (0–240 s) and immediately stored at20 °C.
Luciferin-luciferase experiments were performed at room tem-
perature, and light emission acquisition was performed 20 s
after the addition of luciferin-luciferase to the collected sample.
Measurement of [Ca2]i—Changes in [Ca2]iweremeasured
with the calcium-sensitive dye Fluo-4 NW using the multide-
tection microplate reader referred to above (15). Human fibro-
blasts were seeded in flat bottom 96-well plates at a density of
3  104 cells/ml. Cells were cultured for 5–15 days in supple-
mented DMEM as described above. On the day of the experi-
ment, cells were washed twice with Tyrode’s solution and incu-
bated at 37 °C for 45 min with the cell-permeant fluorescent
Ca2 indicator, Fluo-4 NW (2.5M). After removal of the fluo-
rophore loading solution, cells were washed again twice, and
150/300 l of Tyrode’s solution was added per culture well/
dish, respectively. For the recordings, temperature was main-
tained at 32 °C, and readings were carried out during30 min
each every 5 s, using a tungsten halogen lamp. Fluorescencewas
excited at 485/20 nm, and emission was measured at 528/20
nm. Calcium measurements were calibrated to the maximal
calcium load produced by ionomycin (5 M; 100% response)
(16, 17).
Single-cell [Ca2]i Imaging and To-Pro3 Dye Uptake Detec-
tion by Confocal Microscopy—In some of the experiments, we
monitored single-cell [Ca2]i oscillations and To-Pro3 dye
uptake from the same cells by confocal microscopy (FV1000,
Olympus, Japan) (11). Due to their highmolecularmass, carbo-
cyanine monomer nucleic acid fluorescent dyes, like To-Pro3
(671 Da), are membrane-impermeable and are generally
excluded from viable cells unless large diameter pores open.
Thus, increases in fluorescence intensity can be taken as mea-
sure of To-Pro3 dye uptake into viable cells, which may occur
through connexin and pannexin-1 hemichannels that conduct
molecules up to 1 kDa in size across the plasma membrane
(ATP is 507 Da). Human subcutaneous fibroblasts were seeded
onto 35-mmglass bottom dishes at a density of 2 104 cells/ml
and allowed to grow for 5–15 days in supplemented DMEM, as
described above. On the day of the experiment, cells were first
loadedwith the fluorescentCa2 indicator, Fluo-4NW(2.5M;
see above). Culture dishes were mounted on a thermostatic
(32 °C) perfusion chamber at the stage of an inverted laser-
scanning confocal microscope equipped with a20magnifica-
tion objective lens (LUCPLFLN 20 PH; numerical aperture,
0.45). The chamber was continuously superfused (1 ml/min)
with gassed (95% O2, 5% CO2, pH 7.4) Tyrode’s solution. To
monitor histamine-induced hemichannels opening in parallel
to [Ca2]i oscillations, To-Pro3 iodide (1 M) was added to the
superfusion solution 6 min before histamine application and
was kept up to the end of the experiment. Fluo-4 NW was
excited with a 488-nm multiline argon laser, and the emitted
fluorescence was detected at 510 560 nm; TO-PRO-3 was
excited with a 633-nm red helium-neon laser, and the emitted
fluorescence was detected at 661 nm. Time-lapse sequences
were recorded at scanning rates with a 20-s interval for 30
min, digitized, and processed off-line. Regions of interest were
defined manually.
Cell Viability/Proliferation—Viability/proliferation studies
included the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazo-
lium bromide (MTT)4 assay as described previously (18).
Human fibroblasts were seeded in flat bottom 96-well plates at
a density of 3  104 cells/ml and cultured in supplemented
DMEM as described above. Cell cultures were routinely moni-
tored by phase-contrast microscopy and characterized at days
1, 7, 14, 21, and 28. TheMTT assay consists of the reduction of
MTT to a purple formazan reaction product by viable cells. In
the last 4 h of each test period, cells were incubated with 0.5
mg/ml MTT for 4 h in the conditions described above. The
medium was carefully removed and decanted, and the stained
product was dissolved with DMSO before absorbance (A)
determination at 600 nm using a microplate reader spectrom-
eter. Results were expressed as A/well.
Total Type I CollagenDetermination—Type I collagen deter-
mination was performed using the Sirius Red staining assay.
Human fibroblasts were cultured as described for the viability/
proliferation studies. The staining protocol was adapted from
Tulberg-Reinert and Jundt (19). Cell layers were washed twice
in PBS before fixation with Bouin’s fluid for 1 h. The fixation
fluid was removed by suction, and the culture plates were
washed by immersion in running tap water for 15 min. Culture
dishes were allowed to air-dry before adding the Sirius Red dye
(Direct Red 80). Cells were stained for 1 h under mild shaking
on a microplate shaker. To remove non-bound dye, stained
cells were washed with 0.01 N hydrochloric acid and then dis-
solved in 0.1 N sodium hydroxide for 30 min at room tempera-
ture using amicroplate shaker.Optical density wasmeasured at
550 nm against 0.1 N sodium hydroxide as a blank (19). Results
were expressed as A/well.
Enzymatic Kinetic Experiments and HPLC Analysis—After a
30-min equilibration period at 37 °C, culture day 11 cells were
incubated with 30 M ATP, ADP, or AMP, which was added to
the culturemediumat zero time. Samples (75l) were collected
from each well at different times up to 30 min for high perfor-
mance liquid chromatography (HPLC) (LaChrome Elite, Merck)
analysis of the variation of substrate disappearance and product
formation (11, 20). ATP and ADP catabolism analysis was per-
formed by ion pair reverse-phase HPLC (21), whereas AMP
catabolism analysis used a linear gradient (100% 100 mM
KH2PO4, pH 7, to 100% 100mMKH2PO4, pH 7, 30%methanol)
for 10minwith a constant rate flowof 1.25ml/min.Under these
conditions, the retention times of metabolites were as follows:
AMP (2.17 min), hypoxanthine (3.07 min), inosine (5.09 min),
and adenosine (7.51 min). Concentrations of the substrate and
products were plotted as a function of time (progress curves).
The following parameters were analyzed for each progress
curve: half-life time (t1⁄2) of the initial substrate, time of appear-
ance of the different concentrations of the products, and con-
centration of the substrate or any product remaining at the end
of the experiment.
The spontaneous degradation of adenine nucleotides and
nucleosides at 37 °C in the absence of the cells was negligible
(0–3%) over 30min. At the end of the experiments, the remain-
ing incubation medium was collected and used to quantify the
lactate dehydrogenase (EC 1.1.1.27) activity. The negligible
activity of lactate dehydrogenase in the samples collected at
the end of the experiments is an indication of the integrity of the
cells during the experimental period.
Antibody Production—The development and specificity of
anti-human nucleoside triphosphate diphosphohydrolase 2
(NTPDase2) and NTPDase3 has been reported previously
(22, 23). Hartley guinea pigs and New Zealand rabbits were
obtained from Charles River Laboratories (Que´bec, Canada).
The genetic immunizationprotocolwas carried outwith plasmids
(pcDNA3forhumanNTPDase1andpcDNA3.1 forhumanCD73)
encoding each protein using New Zealand rabbits for antibodies
against human NTPDase1 and Hartley guinea pigs for human
CD73 antibodies.
4 The abbreviations and trivial names used are: MTT, thiazolyl blue formazan,
1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan; AR-C 66096, 2-(propyl-
thio)adenosine-5-O-(,-difluoromethylene)triphosphate tetrasodium
salt; ATPS, adenosine 5-[-thio]triphosphate tetralithium salt; BFA,
brefeldin A; CBX, carbenoxolone; Cx, connexin; NTPDase, nucleoside
triphosphate diphosphohydrolase; E-NTPDase, ecto-nucleoside tri-
phosphate diphosphohydrolase; H1152, (S)-()-2-methyl-1-((4-methyl-5-
isoquinolinyl)sulfonyl)-hexahydro-1H-1,4-diazepine dihydrochloride; Hist,
histamine; MFQ, mefloquine; MRS 2179, 2-deoxy-N6-methyladenosine
3,5-bisphosphate tetrasodium salt; MRS 2211, 2-((2-chloro-5-nitro-
phenyl)azo)-5-hydroxy-6-methyl-3-((phosphonooxy)methyl)-4-pyri-
dinecarboxaldehyde disodium salt; Panx, pannexin; PPADS, 4-((4-formyl-
5-hydroxyl-6-methyl-3-((phosphonooxy)methyl)-2-pyridinyl)azo)-1,3-
benzenedisulfonic acid tetrasodium salt; RB-2, reactive blue 2; TNP-ATP,
2,3-O-(2,4,6-trinitrophenyl)adenosine-5-triphosphate tetra(triethyl-
ammonium) salt; U73122, 1-(6-(((17)-3-methoxyestra-1,3,5(10)-trien-17-
yl)amino)hexyl)-1H-pyrrole-2,5-dione.
Immunocytochemistry—Human fibroblasts were seeded in
chamber slides at a density of 2.5 104 cells/ml and allowed to
grow for 5–15 days. Cultured cells were fixed in 4% paraformal-
dehyde in PBS for 10 min, washed three times in PBS (10 min
each), and subsequently, incubated with blocking buffer I (10%
FBS, 1% bovine serum albumin (BSA), 0.1% Triton X, 0.05%
NaN3) for 1 h. Primary antibodies, diluted in blocking buffer II
(5% FBS, 1% BSA, 0.1% Triton X, 0.05% NaN3), were applied
(mouse anti-porcine vimentin (1:75) (DAKO,Denmark); rabbit
anti-human collagen I (1:50) (AbDSerotec); rabbit anti-human
P2Y1 (1:50), rabbit anti-human P2Y12 (1:100), and rabbit anti-
human P2Y13 (1:25) (Alomone); rabbit anti-human Cx43 (1:600)
and rabbit anti-human pannexin 1 (Panx1) (1:1000) (Abcam);
and rabbit anti-human NTPDase1 (1:100), rabbit anti-human
NTPDase2 (1:200), mouse anti-human NTPDase3 (1:200), and
guineapig anti-humanCD73 (1:300) (University of Laval,Que´bec,
Canada); see the Centre de Recherche duCHULWeb site for fur-
ther details), and the slideswere incubated overnight at 4 °C.After
incubation, cells were washed three times in 1 PBS (10 min
each). The donkey anti-rabbit IgG Alexa Fluor 488, donkey
anti-mouse IgG Alexa Fluor 488, donkey anti-mouse IgG
Alexa Fluor 568, and donkey anti-guinea pig IgG Alexa Fluor
568 secondary antibodies (Invitrogen) were diluted in block-
ing buffer II (5% FBS, 1% BSA, 0.1% Triton X) and applied for
1 h in the dark. A last wash was performed with 1 PBS, and
glass slides were mounted with VectaShield medium and
stored at 4 °C. Observations were performed and analyzed
with an Olympus FV1000 confocal microscope (11, 24).
SDS-PAGE and Western Blotting—Fibroblasts were homog-
enized in a lysis buffer with the following composition: 50 mM
Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% sodium deoxycholate,
1% Triton X-100, 0.1% SDS, and a protease inhibitor mixture.
Protein content of the samples was evaluated using the BCA
protein assay kit according to the manufacturer’s instructions
(Pierce). Samples were solubilized in SDS reducing buffer
(0.125 mM Tris-HCl, 4% SDS, 0.004% bromphenol blue, 20%
glycerol, and 10% 2-mercaptoethanol, pH 6.8, at 70 °C for 10
min), subjected to electrophoresis in 10% SDS-polyacrylamide
gels, and electrotransferred onto PVDFmembranes (MilliPore,
MA). Protein loads were 60 g for P2Y1, P2Y12, and P2Y13, 25
g for Panx1, and 15 g for Cx43. The membranes were
blocked for 1 h in Tris-buffered saline (TBS; 10 mM Tris-HCl,
pH 7.5, 150 mM NaCl) containing 0.05% Tween 20  5% BSA.
Membranes were subsequently incubated with goat anti-hu-
man P2Y1 (1:200) (Santa Cruz Biotechnology, Inc.), rabbit anti-
human P2Y12 (1:200) (Alomone), rabbit anti-human P2Y13
(1:200) (Alomone), rabbit anti-human Panx1 (1:250) (Novex,
Invitrogen), and rabbit anti-human Cx43 (1:6000) (Abcam) in
the above blocking buffer overnight at 4 °C. Membranes were
washed three times for 10 min in 0.1% Tween 20 in TBS and
then incubated with donkey anti-rabbit IgG (HRP) (1:30,000)
(Abcam) and donkey anti-goat IgG (HRP) (1:25,000) (Abcam)
secondary antibodies for 60 min at room temperature. For
comparisonpurposes, themembraneswere also incubatedwith
rabbit anti-human -tubulin (1:2500) (Abcam) antibody fol-
lowing the procedures described above. Membranes were
washed three times for 10 min, and antigen-antibody com-
plexes were visualized by chemiluminescence with an ECL rea-
gent using the ChemiDoc MP imaging system (Bio-Rad).
Presentation of Data and Statistical Analysis—Data are
expressed as mean S.E. from n number of experiments/cells/
individuals. Data from different individuals were evaluated by
one-way analysis of variance. Statistical differences found
between control and drug-treated cultures were determined by
Bonferroni’smethod. p values of0.05 were considered to rep-
resent significant differences.
RESULTS
Fibroblast Characterization—Cultured cells were elongated
and showed a spindle-shapedmorphology that is characteristic
of fibroblasts (25, 26). Their fibroblastic nature was confirmed
by immunocytochemistry. All cells exhibited a positive immu-
noreactivity against vimentin, the intermediate protein fila-
ment considered a reliable fibroblast cell marker (Fig. 1A) (27).
Cells also stained positive for type I collagen (Fig. 1B), which is
highly produced by fibroblasts (27).
Histamine Recruits Ca2 from Intracellular Stores via the
Activation of H1 Receptors Coupled to Phospholipase C—Incu-
bation of human subcutaneous fibroblasts with histamine (100
M, n 34) caused a fast (within seconds) rise in [Ca2]i, which
attained 35  2% of the maximal calcium load produced by
ionomycin (5M; 100% response) (Fig. 2B). Although the kinet-
ics of [Ca2]i rise induced by histamine differed slightly among
cells (see Fig. 2B, iv), the initial fast phase was always followed
by a slow decay lasting about 2 min; beyond that point, [Ca2]i
levels remained fairly constant until drug washout (Fig. 2B, iii).
Histamine-induced [Ca2]i oscillations were significantly
(p 0.05) attenuated by selective blockade ofH1 receptors with
cetirizine, applied in a concentration (1 M, n  6) that on its
own did not change base line (Fig. 2C). Phospholipase C
involvement in histamine-induced [Ca2]i response was con-
firmed using the phospholipase C inhibitor U73122 (3 M, n
6) (Fig. 2D). [Ca2]i oscillations produced by histamine (100
M, n  10) were also prevented (p  0.05) by the selective
inhibitor of endoplasmic reticulumCa2-ATPase, thapsigargin
(2 M, n  4), which is known to deplete intracellular Ca2
stores following a transient (2-min) rise of [Ca2]i levels (28)
(Fig. 2E). The removal of external Ca2 (Ca2-free medium
plus EGTA; 100 M, n  4) depressed (p  0.05) only the late
component of histamine (100 M, n  13) response, keeping
constant the initial fast rise (Fig. 2F).
FIGURE 1. Immunocytochemistry staining of fibroblasts isolated from
human subcutaneous tissue. Cells exhibited positive immunoreactivity
against vimentin, which has been described as a reliable fibroblast marker
(red) (A). Most of the cells also stained positive to type I collagen (green) (B),
which is highly produced by activated fibroblasts. C, merge of vimentin and
type I collagen staining. Scale bar, 60 m.
Histamine-induced [Ca2]i Accumulation Is Partially Depen-
dent on ATP Release, Leading to P2 Purinoceptor Activation—Us-
ing the luciferin-luciferase bioluminescence assay, results show
that histamine (100 M) significantly (p  0.05) increased ATP
release from human subcutaneous fibroblasts as compared with
the control situation where the cells were exposed to Tyrode’s
solution (Fig. 3A).
Extracellular ATP inactivation with apyrase (2 units/ml, n
9) reduced significantly (p 0.05) the late component of hista-
mine (100 M, n 26) response while keeping fairly conserved
the magnitude of the initial [Ca2]i rise (Fig. 3B, i). A similar
pattern was observed when human subcutaneous fibroblasts
were preincubated with non-selective P2 antagonists, RB-2
(100 M, n 7) and PPADS (100 M, n 6) (Fig. 3B, ii and iii,
respectively). Attenuation of histamine-induced [Ca2]i oscil-
lations by PPADS and RB-2 (p  0.05) contrasts with the
absence of effect obtained with the preferential P2X receptor
antagonist, TNP-ATP (10 M, n 2) (data not shown).
In line with these observations, exogenous application
of ATP and ADP (0.1–1 mM) concentration-dependently
increased [Ca2]i; when applied at a 1 mM concentration, ATP
and ADP transiently increased [Ca2]i, reaching 43 4% (n
26) and 25 8% (n 3), respectively, of the maximal calcium
load caused by ionomycin within 20 s from drug application.
ATP-induced [Ca2]i transients were prevented (p  0.05) by
preincubation of human subcutaneous fibroblasts with PPADS
(300 M) (Fig. 3B, iv).
Histamine-induced [Ca2]i Mobilization Depends on Pan-
nexin-1 Hemichannel Activity—Given that histamine-induced
[Ca2]i oscillations inhuman subcutaneous fibroblasts depend, at
least partially, on the release of ATP and subsequent P2 purino-
ceptor activation, we tested the action of selective inhibitors of
nucleotide-releasing pathways on histamine [Ca2]i responses.
Cx43 expression is characteristic of fibroblasts from other
tissue origins (1, 29), and connexin-containing hemichannels
are putative mediators of ATP translocation into the extracel-
lular milieu. Inhibition of connexin hemichannels, either with
mefloquine (MFQ; 3 M, n  4), which has been described as
completely blockingCx36- andCx50-containing hemichannels
(30, 31), or with 2-octanol (1 mM, n  7), which blocks Cx43,
Cx46, and Cx50 hemichannels (31, 32), failed to modify (p 	
0.05) histamine-induced [Ca2]i signals (Fig. 4A, i and ii,
respectively). Despite the fact that 2-octanol (1 mM, n  7)
failed to modify [Ca2]i rises caused by histamine (100 M), we
FIGURE 2. Histamine recruits Ca2 from intracellular stores via the activation of H1 receptors. A and B, fluorescence [Ca
2]i oscillations in human
subcutaneous fibroblasts in culture in the absence (A) and in thepresence (B) of histamine (Hist) (100M). Cellswerepreincubatedwith the fluorescent calcium
indicator Fluo-4 NW; changes in fluorescence were detected in the time-lapse mode using a confocal microscope (A (i and ii) and B (i and ii)) or a microplate
reader (A (iii) and B (iii)) (see “Experimental Procedures”). Note that the kinetics of [Ca2]i signals produced by histamine differed slightly among cells (B, iv).
[Ca2]i transientswere calibrated to themaximal calcium load produced by ionomycin (5M; 100% response). Shown are also [Ca
2]i oscillations produced by
Hist (100 M) applied in the presence of the selective H1 receptor antagonist cetirizine (1 M; C), the phospholipase C inhibitor U73122 (3 M; D), and the
selective endoplasmic reticulumCa2-ATPase inhibitor thapsigargin (2M; E) and after removal of extracellular Ca2 (Ca2-freemediumplus EGTA, 100M; F).
Black arrows, time of drug application. Each point represents pooled data from n experiments. Vertical bars, S.E., shown when they exceed the symbols in size.
Image scale bars, 20 m. *, p 0.05, significant differences from Hist (100 M) alone.
re-evaluated the effect of MFQ, increasing its concentration to
30M, which is high enough to completely block Cx43-contan-
ing hemichannels (31). Unfortunately, on its own,MFQ (30M,
n 3) produced an as yet unexplained rise (p 0.05) in [Ca2]i,
thus precluding further studies to test the histamine response
(data not shown).
Carbenoxolone (CBX; 300 M, n 5), a non-selective inhib-
itor of connexins Cx26, Cx30, Cx32, Cx43, and Cx46, which
also blocks Panx1-containing hemichannels (32), significantly
(p 0.05) attenuated histamine-induced [Ca2]i response (Fig.
4A, iii). The inhibitory effect of CBX (300 M) was reproduced
by the selective Panx1 mimetic inhibitory peptide, 10Panx (100
M, n 6) (33) (Fig. 4A, iv), as well as by probenecid (150 M,
n  4) (34), a powerful inhibitor of Panx1 hemichannels with-
out any action on connexin-containing channels (Fig. 4A, v).
Compounds that affect hemichannel pore permeability, like the
Rho kinase inhibitorH1152 (3M,n 6), also significantly (p
0.05) decreased histamine-induced [Ca2]i rise (Fig. 4A, vi).
Using immunofluorescence confocal microscopy andWestern
blot analysis, we confirmed that fibroblasts of the human subcuta-
neous tissue in culture express both Cx43 and Panx1 (Fig. 4B).
Despite this, data suggest that ATP release via Panx1 hemichan-
nels play a more relevant role in histamine-evoked [Ca2]imobi-
lization under the present experimental conditions.
The uptake of highmolecularmassmembrane-impermeable
fluorescent dyes, such as To-Pro3, has been used to investigate
hemichannels opening (leading to the release of ATP) in viable
cells by time-lapse fluorescence microscopy (35). Data pre-
sented in Fig. 5 show that perfusion of cultured fibroblasts from
FIGURE 3. Histamine-induced [Ca2]i mobilization in cultured human
subcutaneous fibroblasts is partially dependent on ATP release and P2
purinoceptors activation. A, ATP content (nM) of samples from the incuba-
tion medium in the presence of Hist (100 M) as compared with the control
condition where only Tyrode’s solution was applied (luciferin-luciferase ATP
bioluminescence assay). Each bar represents pooled data from 2–3 replicates
of one individual. The vertical bars represent S.E. B, the effect of Hist (100 M)
after pretreatment of the cells with apyrase (2 units/ml) (i), which catabolizes
ATP and ADP into AMP, and two P2 receptor antagonists, RB-2 (100 M) (ii)
and PPADS (100 M) (iii). For comparison purposes, we also tested the effect
of ATP (1mM) (iv) on [Ca2]i oscillations in the absence and in the presence of
PPADS (300 M). Cells were preincubated with the fluorescent calcium indi-
cator Fluo-4 NW (see “Experimental Procedures”); [Ca2]i transients were cal-
ibrated to the maximal calcium load produced by ionomycin (5 M; 100%
response). Black arrows, time of drug application. No changes in base-line
fluorescencewere observed after application of apyrase and the two P2 puri-
noceptor antagonists. Eachpoint represents pooleddata fromnexperiments.
Vertical bars, S.E., shown when they exceed the symbols in size. *, p  0.05,
significant differences from Hist (100 M) or ATP (1 mM) alone.
FIGURE4.Histamine-induced [Ca2]imobilizationdependsonpannexin-1hemichannelactivity inculturedhumansubcutaneous fibroblasts.Theeffectof
Hist (100M)wastested inthepresenceof inhibitorsofconnexin-and/orpannexin-containinghemichannels,namelyMFQ(3M) (A, i),2-octanol (1mM) (A, ii),CBX(300
M) (A, iii), 10Panx (100 M) (A, iv), probenecid (150 M) (A, v), and H1152 (3 M) (A, vi) as well as upon blocking vesicle exocytosis with BFA (20 M) (C). Cells were
preincubated with the fluorescent calcium indicator Fluo-4 NW (see “Experimental Procedures”); [Ca2]i transients were calibrated to the maximal calcium load
produced by ionomycin (5 M; 100% response). Black arrows, time of drug application. None of the inhibitors significantly changed base-line fluorescence when
appliedalone.Eachpoint representspooleddata fromnexperiments.Verticalbars, S.E., shownwhentheyexceedthe symbols in size. *,p0.05, significantdifferences
from Hist (100 M) alone. B, representative confocal micrographs and blots of Cx43 and Panx1 hemichannel immunoreactivity in cultured human subcutaneous
fibroblasts from several distinct individuals (a–g).-Tubulinwas used as a reference protein. Image scale bars, 60m.
the human subcutaneous tissue with histamine (100 M)
caused a sustained rise of To-Pro3 dye uptake (Fig. 5A, i), which
reached a maximum 30–40 s after the initial [Ca2]i peak (Fig.
5A, ii). Compounds that block Panx1-containing channels, like
CBX (300 M, n 7), or affect hemichannel pore permeability,
like H1152 (3 M, n  20), significantly (p  0.05) decreased
histamine-induced [Ca2]i rise and To-Pro3 dye uptake by
human subcutaneous fibroblasts (Fig. 5B).
The involvement of nucleotide release by exocytosis was
assessed using the vesicular transport inhibitor brefeldin A
(BFA; 20 M). No statistically significant (p	 0.05) differences
were found in [Ca2]i oscillations produced by histamine (100
M) in the absence and in the presence of BFA (20 M, n  7;
Fig. 4C).
Histamine Promotes the Growth of Human Subcutaneous
Fibroblasts via H1 Receptor Activation—Previous reports from
the literature demonstrate that histamine promotes fibrosis in a
number of different tissues (e.g. lung and skin) by increasing the
proliferation of fibroblasts (36, 37), yet the role played by hista-
mine-induced ATP release and subsequent P2 purinoceptor
activation in the growth of human subcutaneous fibroblasts has
not yet been investigated. Fig. 6A (i) shows that cultures grown
for 28 days in control conditions exhibited a gradual rise in cell
viability/proliferation throughout the test period. Results con-
cerning type I collagen production followed a pattern similar to
that obtained in the MTT assay (Fig. 6B, i), indicating that
under the present experimental conditions, the amount of
extracellular matrix being produced depends directly on the
number of viable cells in the culture.
Continuous application of histamine (10–100M) to the cul-
ture medium concentration-dependently increased (p  0.05)
human subcutaneous fibroblast proliferation from the first
week onward. At days 21 and 28, the MTT reduction values
increased (p 0.05) by 16 4 and 27 5%, respectively, in the
presence of 100Mhistamine (n 6), as comparedwith control
values (Fig. 6A, ii). Histamine (100 M)-induced cells growth
was significantly (p  0.05) attenuated in the presence of the
selective H1 receptor antagonist, cetirizine (1 M, n 3). Ceti-
rizine (1 M) per se was devoid of a significant (p	 0.05) effect
(data not shown).
The results concerning type I collagen production are shown
in Fig. 6B (ii). Continuous treatment of the cells with histamine
(10–100 M) progressively increased (p 0.05) type I collagen
production from the second week onward in a concentration-
dependent manner. A maximal increase (24  4%) of type I
collagen productionwas obtained onday 28when the cellswere
incubated with 100Mhistamine (n 6) (Fig. 6B (ii)). Selective
blockade of the H1 receptor with cetirizine (1M, n 3) signif-
icantly (p  0.05) attenuated the increase of type I collagen
production caused by histamine (100 M).
Because the amount of type I collagen produced depends on
the number of viable cells in the culture (see above), we normal-
ized Sirius Red absorbance values by the corresponding MTT
values. This normalization eliminated the differences (p	 0.05)
from the control situation detected on type I collagen produc-
tion in the presence of histamine (100 M) (Table 1).
Histamine-induced Human Fibroblast Growth Is Partially
Dependent on P2Y1 Purinoceptor Activation—Given that hista-
mine promotes ATP release, we hypothesized that adenine
nucleotides could be involved in the proliferative response of
human fibroblasts to histamine. Continuous application of
ATP (100 M, n  4) and ADP (100 M, n  4) to the culture
medium increased (p 0.05) cell growth (MTT assay; Fig. 6A,
iii) and type I collagen production (Sirius Red assay; Fig. 6B, iii)
FIGURE 5. Histamine-induced single-cell [Ca2]i oscillations and To-Pro3
dye uptake by cultured fibroblasts of the human subcutaneous tissue
evaluated by time-lapse fluorescence confocal microscopy. A, fluores-
cence variation in cells preloaded with the fluorescent calcium indicator
Fluo-4 NW (see “Experimental Procedures”); To-Pro3was added to the super-
fusion fluid 6 min before Hist (100 M) (dashed vertical line). Results are in
arbitrary units (a.u.) of fluorescence; individual [Ca2]i transients were cali-
brated to thecorrespondingmaximal calcium loadproducedby ionomycin (5
M; 100% response) in the same cell. B, bars represent the effect of Hist (100
M) in the absence and in the presence of pannexin-1 hemichannel permea-
bility blockers, CBX (300M) andH1152 (3M). Vertical bars, S.E. from n exper-
iments. *, p 0.05, significant differences from control values obtained in the
absence of tested drugs; **, p 0.05, significant differences compared with
the effect of Hist (100 M) alone.
by human subcutaneous fibroblasts from the second week
onward. The pattern of nucleotide responseswas similar to that
obtained with histamine (100 M) (Fig. 6, A (ii) and B (ii),
respectively). Normalization of type I collagen production by
the content of viable cells also eliminated the differences (p 	
0.05) from the control situation (Table 1), indicating that (like
histamine) adenine nucleotides have a net proliferative effect
on human fibroblasts, thereby increasing type I collagen con-
tent of the cultures. Interestingly, the enzymatically stable ATP
analog, ATPS (100 M, n 3), failed to reproduce the prolif-
erative effect of ATP (100 M) (Fig. 6, A (iii) and B (iii)), thus
suggesting that ATP has to be catabolized into ADP in order to
promote growth of human subcutaneous fibroblasts.
To investigate the contribution of ADP-sensitive P2Y puri-
noceptor activation to histamine-induced growth of human
subcutaneous fibroblasts, we tested its effect in the presence of
selective P2Y1, P2Y12, and P2Y13 receptor antagonists (Fig. 7A).
Selective blockade of the P2Y1 receptorwithMRS2179 (0.3M)
significantly (p  0.05) attenuated the proliferative action of
histamine (100 M), but no significant differences (p 	 0.05)
were observed in the presence of AR-C 66096 (0.1 M) and
MRS 2211 (10 M) which selectively antagonize P2Y12 and
P2Y13 receptors, respectively (Fig. 7A). None of these antag-
onists modified per se human fibroblast proliferation (data
not shown).
The presence of ADP-sensitive P2Y purinoceptors in
cultured human subcutaneous fibroblasts was confirmed by
immunocytochemistry (Fig. 7B) and Western blot (Fig. 7C)
analysis. Fluorescence immunoreactivity showed a cytoplas-
mic/membrane-staining pattern. The P2Y1 receptor immuno-
reactivity was the most intense, followed by P2Y12 and P2Y13
purinoceptors, which exhibited less significant labeling inten-
sity (Fig. 7B). As illustrated by the Western blots shown in Fig.
7C (i), the expected protein bands of human P2Y1 (63 kDa),
P2Y12 (50 kDa), and P2Y13 (41 kDa) receptors were detected in
homogenates from cultured subcutaneous fibroblasts obtained
from all tested individuals (a, b, and c). The labeling density of
ADP-sensitive P2Y receptors normalized to -tubulin bands
indicates that the P2Y1 is the most expressed receptor in cul-
tured human subcutaneous fibroblasts (Fig. 7C, ii).
FIGURE 6. Proliferation/viability and type I collagenproduction byhuman
subcutaneous fibroblasts grown for 28 days in culture; role of histamine
andadeninenucleotides, ATP,ADP, andATPS.A (i), viability/proliferationof
cells measured by the MTT assay; results are expressed as absorbance determi-
nationat600nm/well at certain timepoints.B (i), total type I collagenproduction
assessed by Sirius Red staining; results are expressed as absorbance determina-
tionat550nm/well at certain timepoints.Hist (100M)withorwithout cetirizine
(selective H1 receptor antagonist; 1M), ATP (100M), ADP (100M), andATPS
(100 M) were all applied continuously to the culture medium. The ordinates
represent changes in cell growth (MTT values; A, ii and iii) and type I collagen
production (Sirius Red values; B, ii and iii) as compared with controls in the
absence of test drugs at the same timepoints (seeA (i) and B (i)). Zero represents
similarity between the two values (drug versus control); positive and negative
values represent facilitation or inhibition of either cell growth or type I collagen
production relative tocontroldataobtainedat thesametimepoints.Cetirizine (1
M) per sewas devoid of effect. Each bar represents pooled data from 3–6 indi-
viduals; 4–8 replicas were performed for each individual experiment. Vertical
bars, S.E. *, p 0.05, significant differences from control values obtained in the
absence of tested drugs; #, p 0.05, significant differences compared with the
effect of Hist (100M) alone.
TABLE 1
Normalizationof type I collagenproductionvalues tocell growth (MTT
assay values) in human subcutaneous fibroblasts grown in culture for
28 days
Histamine (100M), ATP (100M), and ADP (100M) were added continuously to
the culture media of human subcutaneous fibroblasts. Because the amount of type I
collagen produced depends on the number of viable cells in culture, we normalized
Sirius Red absorbance values by the corresponding MTT values. Values are
means  S.E. from 4–6 individuals; 4–8 replicas were performed for each indivi-
dual experiment. *, p 0.05, significant differences from control values obtained in
the absence of tested drugs. n.s., no significance.
Pattern of the Extracellular Catabolism of Adenine Nucleo-
tides in Human Subcutaneous Fibroblast Cultures—Fig. 8 illus-
trates the time course of the extracellular catabolism of adenine
nucleotides, ATP, ADP, and AMP, in the first subculture of
fibroblasts isolated from the human subcutaneous tissue. ATP
(30 M) was metabolized with a half-life time of 21.7 1.4 min
(n  4 observations from two individuals). The ATP metabo-
lites detected in the bath were ADP, adenosine, and inosine,
whose concentrations increased progressivelywith time, reach-
ing maximal values of 3.7  0.7, 11.1  0.8, and 6.3  0.5 M,
respectively, 30 min after ATP (30 M) application (Fig. 8A, i).
The extracellular catabolism of ADP (30 M) was significantly
(p 0.05) slower (half-life time of 36.8 3.2 min, n 4 obser-
vations from two individuals) than that of ATP (30 M). ADP
wasmetabolized into adenosine and inosine, whose concentra-
tions increased with time, reachingmaximal values of 6.6 1.7
and 6.4 2.3M, respectively, 30min after ADP (30M) appli-
cation (Fig. 8A, ii). Interestingly, AMP (30M)was almost com-
pletely dephosphorylated into adenosine and inosine with a
half-life time of 2.9  0.7 min (n  4 observations from two
individuals), which might explain why the accumulation of
AMPwas almost negligible (less than 1 M) when ATP (30M)
and ADP (30 M) were used as substrates (Fig. 8A, iii).
Given the linearity of the semilogarithmic representation of
progress curves obtained by polynomial fitting of the catabo-
lism of ATP (y0.0134x 1.3631, R2 0.9334), ADP (y
0.0078x 1.4118, R2 0.8850), and AMP (y0.0610x
1.2594, R2 0.9096), the analysis of the corresponding half-life
FIGURE 7. Histamine-induced human fibroblast growth is partially
dependentonP2Y1purinoceptor activation.A, the variationof cell growth
caused by continuous application of Hist (100 M) to the culture medium in
the absence and in the presence of selective P2Y1, P2Y12, and P2Y13 receptor
antagonists: MRS 2179 (0.3 M), AR-C 66096 (0.1 M), and MRS 2211 (10 M),
respectively. The ordinates represent changes in MTT values compared with
control cultures grown in the absence of test drugs at the same time points
(see Fig. 4). Zero represents similarity between the two values (drug versus
control); positive and negative values represent facilitation or inhibition of
cell growth relative to the control situation at the same time points. Each bar
represents pooled data from two individuals; four replicates were performed
for each individual experiment. Vertical bars, S.E. *, p 0.05, significant differ-
ences comparedwith the effect of Hist (100M) alone. B, immunoreactivity of
human subcutaneous fibroblasts against P2Y1, P2Y12, and P2Y13 receptors at
cultureday7. Imageswereobtainedunder a confocalmicroscope. Results are
representative of three independent experiments. Scale bar, 20m. C (i), rep-
resentative immunoblots of P2Y1, P2Y12, and P2Y13 receptor expression in
cultured human subcutaneous fibroblasts from three distinct individuals (a,
b, and c). C (ii), quantification of P2Y1, P2Y12, and P2Y13 receptor levels using
-tubulin as a reference protein of experiments shown in C (i).
FIGURE 8. Time course of the extracellular catabolism of adenine nucleo-
tides and immunocytochemical detection of E-NTPDases in human sub-
cutaneous fibroblast cultures atday11.ATP (A, i), ADP (A, ii), andAMP (A, iii)
were added at a concentration of 30 M to the culture medium at time 0.
Samples (75 l) were collected from each well at the times indicated on the
abscissa. Each collected sample was analyzed by HPLC to separate and quan-
tify ATP (filled circles), ADP (open circles), AMP (filled squares), adenosine (open
squares), inosine (filled triangles), or hypoxanthine (open triangles). Each point
represents pooled data from two individuals; two replicas were performed in
each individual experiment. Vertical bars, S.E., shown when they exceed the
symbols in size. The calculated half-life time (t1⁄2, min) for each initial substrate
is shown for comparison. B, immunoreactivity of human subcutaneous fibro-
blasts against E-NTPDase1, E-NTPDase2, E-NTPDase3, and E-5-nucleotidase
(CD73). Cells grown in 8-well chamber slides were processed for immunocy-
tochemistry in parallel andwere visualized, keeping unaltered the settings of
the confocal microscope throughout the procedure. Scale bar, 20 m.
time values clearly indicates that the extracellular catabolism of
ATP/ADP into AMP through E-NTPDases is the rate-limiting
step to generate adenosine from exogenously added adenine
nucleotides, as we previously observed in human bone marrow
stromal cells (11, 18).
The expression of E-NTPDase family members 1, 2, and 3
and of E-5-nucleotidase (also called CD73, EC 3.1.3.5) was
assessed by immunofluorescence confocal microscopy (Fig.
8B). Human subcutaneous fibroblasts exhibited a strong immu-
noreactivity against E-5-nucleotidase (Fig. 8B, iv), thus sup-
porting the high AMP dephosphorylation rate detected in the
enzymatic kinetic studies (Fig. 8A, iii). These cells also stained
positively for E-NTPDase1 (also called CD39 or apyrase, EC
3.6.1.5) (Fig. 8B, i) as well as for E-NTPDase2 (CD39L1, EC
3.6.1.3) (Fig. 8B, ii), although for the latter, the immunoreactiv-
ity was less intense. No immunoreactivity against E-NTPDase3
(CD39L3 or HB6) was detected in these cells (Fig. 8B, iii).
DISCUSSION
Histamine belongs to a group of endogenous chemical sub-
stances that are released upon cell damage or during inflamma-
tory insults (38–40). The role of histamine in nociception is not
clear, but it appears to cooperate with the effect of other endog-
enous mediators (41). It has been shown that histamine,
together with substance P, is capable of inducing ATP release
from smoothmuscle cells of the guinea pig vas deferens (12). To
thebest of ourknowledge, this is the first studydemonstrating that
human fibroblasts isolated from subcutaneous connective tissue
respond to histamine by releasing ATP into the extracellular
media through the activation of H1 receptors.
Results also showed that histamine triggers intracellular Ca2
mobilization via the activation of Gq protein-coupled H1 recep-
tors, given that inhibition of phospholipase C with U73122 and
depletion of intracellular Ca2 stores caused by thapsigargin
attenuated its response. Moreover, extracellular Ca2might also
play somerole to sustain the latecomponentofhistamine-induced
[Ca2]i rise, because its removal from the incubationmedium sig-
nificantly attenuated histamine response. A similar response to
histamine has been reported in epithelial cells (42). Our findings
could be explained by a possible involvement of store-operated
calcium channels in order to compensate for the fall of the
[Ca2]i content (43) and/or through a concurrent activation of
other membrane receptors, namely P2 purinoceptors. Attenu-
ation of histamine-induced [Ca2]i response by apyrase sug-
gests cooperation with a nucleotide mediator, such as ATP
and/or ADP. Because blockade of P2 purinoceptors mimicked
the attenuating effect of apyrase, our data provide the first evi-
dence that histamine-induced [Ca2]i accumulation by fibro-
blasts of human subcutaneous tissue is partially mediated by
the release of ATP and subsequent activation of P2 purinocep-
tors. Recently, it was demonstrated that stretch-induced ATP
release in rat subcutaneous fibroblasts influences cytoskeletal
remodeling of the cells in part by the subsequent activation of
P2 purinoceptors (44).
Depending on the cell type, there are multiple nucleotide-
releasing pathways, which represent a critical component for
the initiation of the purinergic signaling cascade (13). Consid-
ering that Ca2 signaling induced by histamine seems to par-
tially involve P2 purinoceptor activation subsequent to the
release of ATP from fibroblasts of the human subcutaneous
tissue, we assessed the contribution of several nucleotide-re-
leasing mechanisms by measuring [Ca2]i oscillations. Hista-
mine-induced [Ca2]i oscillations were not affected upon inhi-
bition of the vesicular transport with BFA, thus suggesting that
exocytosis might not represent an important pathway for
releasing ATP in these cells. Further studies designed to inves-
tigate unloading of vesicular ATP stores stained with quina-
crine are required to exclude this possibility in human fibro-
blasts (45). Here, we proved that human subcutaneous
fibroblasts express Cx43 and Panx1 hemichannels. Although
both channels have been committed to translocation of nucle-
otides to the extracellular milieu in numerous cell types, func-
tional data using non-selective connexin inhibitors, such as
2-octanol and MFQ, failed to modify histamine-induced
[Ca2]i oscillations in fibroblasts of the human subcutaneous
tissue. Conversely, blockade of Panx1-containing hemichan-
nels with CBX (32), 10Panx (33), and probenecid (34) signifi-
cantly attenuated the histamine-induced [Ca2]i response.
Given that probenecid is a powerful Panx1 inhibitor with no
effect on connexin channels, our findings suggest that Panx1-
containing hemichannelsmight have a predominant role in his-
tamine-induced [Ca2]i responses operated by ATP released
from human subcutaneous fibroblasts. The reason for the dis-
parity between protein expression and function may be that
Cx43, unlike Panx1, hemichannels close at normal millimolar
Ca2 (e.g. 1.8 mM CaCl2 in Tyrode’s solution) and open upon
external Ca2 depletion (46).
The involvement of ATP-releasing hemichannels was fur-
ther confirmed by time-lapse fluorescencemicroscopy demon-
strating the uptake of To-Pro3 by cultured human fibroblasts.
Following the initial [Ca2]i peak, histamine caused a sustained
increase in To-Pro3 dye uptake by the cells, which paralleled
the second component of [Ca2]i rise. Sustained effects of his-
tamine on both [Ca2]i and To-Pro3 dye uptake were signifi-
cantly attenuated upon blocking pannexin-1 hemichannel per-
meability withCBX andH1152, thus implicating the opening of
large membrane pores that facilitate translocation of high
molecularmassmolecules (like ATP) between intra- and extra-
cellular compartments.
The molecular mechanism(s) by which histamine releases
ATP through the opening of Panx1 hemichannels in human
subcutaneous fibroblasts deserves further investigation. Never-
theless, disregarding whether channel-mediated efflux or vesi-
cle exocytosis comprises the predominant ATP release mecha-
nism,most studies have identified elevation of cytosolicCa2 as
an important regulator of ATP release in different cell models.
Generation of inositol trisphosphate by phospholipase C may
be the process underlying elevation of cytosolic Ca2 (47, 48).
Histamine H1 receptor, like other Gq-coupled receptors, may
additionally stimulate Rho-GTPase (via G12/13), acting to
strongly potentiate the Ca2-activated ATP release pathway
(49, 50). Rho activation and Ca2mobilization must be tempo-
rally coordinated to promote ATP release. Interestingly, Semi-
nario-Vidal et al. (50) demonstrated that Ca2- and RhoA/Rho
kinase-dependent ATP release from thrombin-stimulated
A549 lung epithelial cells occurs via connexin or pannexin
hemichannels, but this pathway might not be competent for
ATP release in human astrocytoma cells (49). Given the actions
exerted by Rho/Rho kinase on scaffold proteins and cytoskele-
ton components (e.g. regulating myosin light chain phosphory-
lation and actin polymerization), the authors speculate that
Rho-promotedmembrane-cytoskeleton rearrangements facili-
tate the insertion of hemichannel subunits within the plasma
membrane. Blockade of one of these multiple mechanisms
might explain the attenuating effect of the Rho kinase inhibitor
H1152 on histamine-induced [Ca2]i rise observed in this
study. These findings suggest that RhoA/Rho kinase activation
is a step upstream of Panx1-mediated ATP release triggered by
histamine in human subcutaneous fibroblasts.
Our data also demonstrate that fibroblasts of human subcu-
taneous connective tissue respond to histamine by increasing
cell growth and subsequent type I collagen production through
the activation of H1 receptors. Normalization of type I collagen
production by the number of viable cells indicates that hista-
mine exerts a preferential effect on cell proliferation rather than
in extracellularmatrix remodeling. In lungs and skin, histamine
exerts a profibrotic action by increasing cells growth (36, 37)
and collagen deposition (37, 51) via H2 receptor activation.
Despite the close anatomical proximity between skin and sub-
cutaneous connective tissue, functional differences between
fibroblasts from different tissue origins have been described
(52, 53). Thus, differences between our findings and previous
reports regarding the receptor subtype involved in the action of
histaminemay be explained by differences in tissue and species
origin. On the other hand, distinct methodological approaches
have been used. Previous studies (36, 37, 51) exposed cells to
histamine from several hours to a few days (7 days), whereas we
monitored histamine-induced effects in cells kept in culture for
28 days. Moreover, in contrast to previous studies, we found
significant differences in cell growth and type I collagen pro-
duction induced by histamine (10–100 M) exposure from the
second week onward. Actually, we did not monitor acute (for
hours to a few days) changes operated by histamine in our cul-
tures. These findings strengthen the idea that, although fibro-
blasts are ubiquitousmesenchymal cells, theymay function dif-
ferently depending on their location.
Given that histamine triggered the release of ATP from
human subcutaneous fibroblasts in culture, we postulated that
adenine nucleotides could be involved in the proliferative
response of histamine in these cells. Continuous application of
ATP and ADP to the culture medium mimicked the prolifera-
tive effect of histamine, indicating that adenine nucleotides
promote human fibroblast growth and subsequent type I colla-
gen production. Surprisingly, no such effect was found with the
enzymatically stable ATP analog, ATPS, Thus, it seems that
cells exposed to histamine release ATP into the extracellular
milieu, which, upon conversion into ADP, indirectly promotes
growth of human subcutaneous fibroblasts. In fact, selective
blockade of ADP-sensitive P2Y1 receptors attenuated hista-
mine-induced cell proliferation, but no changes were detected
in the presence of the selective P2Y12 and P2Y13 antagonists.
The presence of P2Y1 receptors in fibroblasts of the human
subcutaneous tissue was confirmed by immunofluorescence
confocalmicroscopy andWestern blot analysis. Data show that
immunoreactivity against the P2Y1 receptor was much more
intense as compared with that of P2Y12 and P2Y13 receptors.
Functional data and immunolabeling experiments are consis-
tent with ADP-sensitive P2Y1 being the receptor subtype medi-
ating the purinergic loop leading to cell growth in response to
histamine. This outcome is particularly interesting considering
that the P2Y1 receptor, alongwith the P2Y2 and P2X7 subtypes,
has been implicated in chronic inflammation (10). These
authors used disks made of non-cytotoxic degradable dermal
sheep collagen implanted subcutaneously in rats tomonitor the
foreign body inflammatory reaction for 21 days. They found
that P2Y1, P2Y2, and P2X7 receptors were up-regulated, in par-
allel to vascular activation and increased number of macro-
phages and giant cells. Although fibroblasts were shown to
encapsulate the disks and to promote deposition of extracellu-
lar matrix components (10), these cells were not further evalu-
ated. Given that inflammatory reactions involve the recruit-
ment of mast cells, which release huge amounts of histamine to
the extracellular milieu, we speculate that activated fibroblasts
would proliferate, thus contributing to the global increase in
P2Y1 receptor expression.
The activity of ecto-nucleotidases is critical to define the
inactivation rate of adenine nucleotides within close proximity
of the release sites in tissue microenvironments. In this study,
we analyzed the role of three members of the ecto-nucleoside
triphosphate diphosphohydrolase (E-NTPDase) family, namely
E-NTPDase1, E-NTPDase2, and E-NTPDase3 (54). These
enzymes have distinct biochemical properties. E-NTPDase1
hydrolyzes ATP and ADP equally well, E-NTPDase2 preferen-
tially hydrolyzes triphosphonucleosides, and E-NTPDase3 has
an intermediate hydrolysis profile (55). The hydrolysis of tri-
and diphosphonucleosides by E-NTPDases yields AMP as the
final product, which can be fully dephosphorylated to adeno-
sine by E-5-nucleotidase/CD73 (56). Our results showed that
human subcutaneous fibroblasts exhibit a strong immunoreac-
tivity against E-5-nucleotidase/CD73, which is in keeping with
a faster conversion of AMP into adenosine. A high E-5-nucleo-
tidase/CD73 activity might also explain why the concentration
of AMP was kept at a low level when ATP and/or ADP were
used as substrates (57).
Luttikhuizen et al. (10) reported the overexpression of sub-
cutaneous E-NTPDase1 in a model of chronic inflammation.
Interestingly, we showed here that human subcutaneous fibro-
blasts express E-NTPDase1 immunoreactivity under resting
conditions. This member of the NTPDase family seems to be
the most expressed ATP- and/or ADP-metabolizing enzyme in
these cells, as predicted from lesser immunofluorescence sig-
nals obtained for other E-NTPDases. These cells exhibit weak
immunoreactivity against E-NTPDase2, and no signal was
detected for E-NTPDase3, suggesting that E-NTPDase2 may
participate together with E-NTPDase1 in the extracellular
catabolism of adenine nucleotides in fibroblasts of the human
subcutaneous tissue. E-NTPDase1, E-NTPDase2, and E-NTP-
Dase3 hydrolyze extracellular tri- and diphosphonucleotides
with ATP/ADP ratios of 1–2:1, 10–40:1, and 3–4:1,
respectively (55). The kinetic analysis of the extracellular catab-
olism of ATP and ADP in human subcutaneous fibroblast
cultures indicates that adenine nucleotides are metabolized
with a ratio of1.5(ATP):1(ADP), which is compatible with
E-NTPDase1 being themost effective isoform in these cultures. In
linewith this hypothesis, one would expect that the formation of
adenosine should be prevented if NTPDase2 acted alone, or it
could be delayed if NTPDases3 was the main enzyme involved
in the catabolism of adenine nucleotides, given that it is well
known that E-5-nucleotidase/CD73 is inhibited by ADP (55,
57). Our results proved exactly the opposite, showing that AMP
wasrapidlydephosphorylated intoadenosine independentlyof the
nucleotide substrate used. On the other hand, involvement of
E-NTPDase1 is expected to terminate the effects exerted by either
ATP- orADP-sensitive receptors. Nevertheless, data indicate that
responses of human subcutaneous fibroblasts to histamine
depend on the activation of ADP-sensitive P2Y1 receptors.
This situation can occur because E-NTPDase2 concurs with
E-NTPDase1 to release enough ADP required to activate P2Y1
receptors in human subcutaneous fibroblasts, because the former
enzyme preferentially hydrolyzes triphosphonucleosides.
In conclusion, our findings showed for the first time that
histamine promotes the release of ATP from human subcuta-
neous fibroblasts via Panx1 hemichannels, leading to [Ca2]i
mobilization from internal stores and cell growth through the
cooperation of H1 and P2Y receptors (most probably of the
P2Y1 subtype) activation. Targeting the pathways leading to
nucleotide release and the purinergic cascade, consisting in
metabolizing E-NTPDase and P2 purinoceptor activation, may
be useful in designing novel therapies toward themodulation of
cell signals between fibroblasts, nociceptors, and inflammatory
cells, which underlie the pathogenesis of painful musculoskel-
etal diseases with widespread involvement of the subcutaneous
connective tissue, such as fibromyalgia.
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